In clinical samples, the co-expression of TGF-β1 and CXCR7 positively correlates with CD44 levels in advanced lung adenocarcinoma, confirming the involvement of CXCL12 in maintaining stem-like properties of NSCLC cells [119]. Here, CD44 is linked to lung adenocarcinoma.